CStone Pharmaceuticals (HKSE:02616) Total Liabilities : HK$0.0 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Total Liabilities?

CStone Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2023 was HK$0.0 Mil.

CStone Pharmaceuticals's quarterly Total Liabilities increased from Jun. 2022 (HK$1,247.36 Mil) to Dec. 2022 (HK$1,327.89 Mil) but then declined from Dec. 2022 (HK$1,327.89 Mil) to Jun. 2023 (HK$0.00 Mil).

CStone Pharmaceuticals's annual Total Liabilities increased from Dec. 2021 (HK$1,303.38 Mil) to Dec. 2022 (HK$1,327.89 Mil) but then declined from Dec. 2022 (HK$1,327.89 Mil) to Dec. 2023 (HK$1,318.19 Mil).

CStone Pharmaceuticals Total Liabilities Historical Data

The historical data trend for CStone Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Total Liabilities Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

521.95

958.18

1,303.38

1,327.89

1,318.19

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial									1,303.38	1,247.36	1,327.89	-	1,318.19

CStone Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CStone Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	930.082	+	(245.154	+	142.952
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,318.2

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1817.859	-	499.671
	=	1,318.2

CStone Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	N/A	-	N/A
	=	N/A

CStone Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (HKSE:02616) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CSPHF:USA PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (HKSE:02616) Headlines

No Headlines